Abn Amro Investment Solutions Exact Sciences Corp Transaction History

Abn Amro Investment Solutions

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Sep 05, 2025	SELL	$56.27 - $73.77 $960,078 - $1.26 Million	-17,062 Closed	0 $0
Q4 2023 Sep 05, 2025	BUY	$59.06 - $75.72 $15,060 - $19,308	255 Added 1.52%	17,062 $1.26 Billion
Q3 2023 Nov 07, 2025	BUY	$65.94 - $99.04 $1.11 Million - $1.66 Million	16,807 New	16,807 $1.15 Billion
Q3 2023 Sep 05, 2025	BUY	$65.94 - $99.04 $612,318 - $919,685	9,286 Added 123.47%	16,807 $1.15 Billion
Q2 2023 Sep 05, 2025	BUY	$62.68 - $95.05 $471,416 - $714,871	7,521 New	7,521 $706 Million

688

164M

2.12M

1.69M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.